A bioink is the printable material that carries living cells through a bioprinter. Choosing one is the single most consequential decision in a bioprinting experiment, because it fixes what you can build, how accurately you can build it, and how many of your cells survive the process.

Bioink or biomaterial ink?

The field draws a distinction that press coverage usually misses. A bioink contains living cells at the moment of printing. A biomaterial ink is printed first and seeded with cells afterwards. Both are legitimate; only the first has to keep anything alive while passing through the nozzle, which is why the terms are not interchangeable.

What a bioink has to do

A bioink has to satisfy a list of requirements that pull against each other:

  • Printability. It must flow under the pressure the printer applies and stop flowing the moment it leaves the nozzle.
  • Shape fidelity. Layer one must still be layer one after layer twenty is deposited on top of it.
  • Cytocompatibility. Nothing in it, and nothing produced while it sets, may poison the cells.
  • Mechanical match. Brain tissue is roughly a thousand times softer than cartilage. Cells read the stiffness of their surroundings and change behaviour accordingly, so a mismatch pushes them towards the wrong identity.
  • Permeability. Oxygen, nutrients and waste have to diffuse through it.
  • Cell adhesion. Most cells need something to grip. Materials that offer no attachment sites have to be modified with peptide sequences such as RGD.
  • Controlled degradation. The gel should disappear at roughly the rate the cells replace it with matrix of their own — too fast and the structure collapses, too slow and the tissue cannot remodel.

No single material does all of this well, which is why almost every serious bioink in use is a blend.

The main materials

Alginate

A polysaccharide extracted from brown seaweed, and the most common starting point in the field. It gels within seconds when exposed to calcium ions, which is gentle, instant and requires no light or heat. It is cheap, reliable and forgiving.

Its drawback is that it is biologically inert. Mammalian cells have no receptors for alginate, so they cannot attach to it and often end up rounded and passive unless the alginate is modified with adhesion peptides. It also degrades unpredictably in the body. Alginate is an excellent scaffold and a poor home.

Gelatin and GelMA

Gelatin is denatured collagen, so it retains the adhesion sites that cells recognise. On its own it is thermally reversible — a gel when cool, a liquid at body temperature — which makes it useless for anything meant to be implanted.

GelMA (gelatin methacryloyl) solves this by chemically decorating gelatin with groups that cross-link permanently under light. Adjusting the degree of substitution and the light dose tunes stiffness across a wide range. GelMA has become the closest thing the field has to a default bioink for soft tissue.

Collagen

The most abundant protein in the human body and, biologically, the most desirable material to print with: cells recognise it, attach to it and remodel it as they would their own matrix. It is also miserable to print. It gels slowly, at low viscosity, and cannot support its own weight in air. The FRESH embedded-printing technique was developed largely to make collagen printable at scale, and it was collagen that Feinberg's group used to print a full-size heart scaffold in 2019.

Fibrin

The protein your body uses to form blood clots, produced by mixing fibrinogen with thrombin. It is strongly pro-angiogenic — endothelial cells sprout readily into it — which makes it valuable wherever a construct needs to build its own microvessels. It is mechanically weak, so it is generally blended with something stiffer.

Hyaluronic acid

A natural component of the extracellular matrix, abundant in cartilage, skin and the vitreous of the eye. It holds enormous amounts of water, supports cell migration and can be chemically modified in many ways. Unmodified, it is too soft to print and clears from the body quickly.

Decellularised extracellular matrix (dECM)

Real tissue — heart, liver, cartilage — stripped of its cells with detergents, leaving behind the native matrix, which is then solubilised into an ink. The result carries the full biochemical signature of the source organ, including growth factors and matrix proteins in roughly native proportions. Constructs made this way encourage cells to adopt tissue-appropriate behaviour better than any synthetic alternative.

The costs are batch-to-batch variability, weak mechanics, and the regulatory burden of a material derived from human or animal tissue.

Synthetic polymers

PEG-based hydrogels, Pluronic and polymers such as PCL and PLGA offer what natural materials cannot: exact, reproducible, tunable properties. PCL is routinely printed alongside a soft bioink to act as a load-bearing frame — the approach used in the Wake Forest ITOP system to give printed ear and bone constructs enough strength to be handled and implanted. Pluronic is the standard sacrificial ink for creating channels. Synthetics carry no biological signals of their own, so they are almost always paired with something that does.

Comparison table

Material Source Cross-linking Cell adhesion Main limitation
AlginateBrown seaweedCalcium ionsNone without modificationBiologically inert
GelMADenatured collagenLightGoodPhotoinitiator toxicity if uncontrolled
CollagenAnimal or recombinantTemperature, pHExcellentVery hard to print unsupported
FibrinBlood plasma proteinsThrombinGoodMechanically weak
Hyaluronic acidNative matrixChemical or lightModerateToo soft unmodified
dECMDecellularised tissueTemperature, lightExcellentVariable batches, weak mechanics
PEGSyntheticLight or chemicalNone without peptidesNo biological signalling
PCLSynthetic thermoplasticCooling from meltPoorPrinted hot, so no cells inside it

Cross-linking: how a printed gel sets

Cross-linking is what turns a viscous liquid into a solid gel, and the mechanism matters as much as the material.

  • Ionic. Calcium bridges alginate chains within seconds. Gentle and instant, but reversible — the gel weakens as ions leach out in culture.
  • Photo-cross-linking. Light plus a photoinitiator forms covalent bonds. Fast, precise and spatially controllable. Ultraviolet light and certain initiators can damage cells, so visible-light systems such as LAP and ruthenium-based initiators have largely displaced older ultraviolet chemistry.
  • Thermal. Collagen and dECM gel as they warm to 37 °C; gelatin does the opposite. Entirely benign to cells, but slow and hard to control precisely.
  • Enzymatic. Thrombin converts fibrinogen to fibrin; transglutaminase links proteins. Highly specific and biologically natural, but slower and more expensive.

Many bioinks use two mechanisms in sequence: a fast ionic or thermal gel to hold the shape during printing, followed by a permanent covalent cure. Dual-network inks of this kind are now common.

The biofabrication window

The central constraint has a name. The biofabrication window is the narrow band of material properties in which an ink is simultaneously printable and hospitable to cells. Push stiffness up and shape fidelity improves while viability falls. Push it down and cells thrive inside a structure that will not stand up.

Almost every strategy in the field is an attempt to widen that window rather than to pick a point inside it:

  • Support baths remove the requirement that the ink hold its own weight, so a much softer material becomes printable.
  • Interpenetrating networks combine a tough polymer with a cell-friendly one, so each contributes what the other lacks.
  • Shear-thinning inks thin dramatically under the pressure of the nozzle and recover instantly on exit, giving low shear stress during printing and high stiffness after it.
  • Cell spheroids sidestep the ink question entirely: pre-formed clusters of cells are placed as building blocks and allowed to fuse, with the surrounding gel acting only as temporary scaffolding.

Where bioink research is heading

Three directions are worth watching. Tissue-specific formulations — dECM inks matched to the target organ — consistently outperform generic hydrogels and are becoming standard practice. Functionalised inks carry growth factors, oxygen-releasing compounds or conductive additives that actively instruct cells rather than merely housing them. And machine-learning-guided formulation is starting to replace the field's traditional trial-and-error search through an enormous compositional space.

Commercially, CELLINK's launch of a universal bioink in 2016 was a turning point: it meant laboratories could buy a validated, reproducible material instead of mixing their own, which made results comparable between groups for the first time. Standardisation, unglamorous as it is, has probably done more for the field's credibility than any single printed organ.


Keep reading

Last reviewed . Educational information only — not medical advice.